Benzazepinone Nav1.7 blockers: potential treatments for neuropathic pain

Bioorg Med Chem Lett. 2007 Nov 15;17(22):6172-7. doi: 10.1016/j.bmcl.2007.09.032. Epub 2007 Sep 11.

Abstract

A series of benzazepinones were synthesized and evaluated as hNa(v)1.7 sodium channel blockers. Several compounds from this series displayed good oral bioavailability and exposure and were efficacious in a rat model of neuropathic pain.

MeSH terms

  • Animals
  • Benzodiazepinones / chemical synthesis*
  • Benzodiazepinones / pharmacokinetics
  • Benzodiazepinones / therapeutic use*
  • Biological Availability
  • Disease Models, Animal
  • Dogs
  • Drug Evaluation, Preclinical
  • Molecular Structure
  • NAV1.7 Voltage-Gated Sodium Channel
  • Neuralgia / drug therapy*
  • Rats
  • Sodium Channel Blockers / chemical synthesis*
  • Sodium Channel Blockers / pharmacokinetics
  • Sodium Channel Blockers / therapeutic use*
  • Sodium Channels / chemistry
  • Sodium Channels / drug effects*

Substances

  • Benzodiazepinones
  • NAV1.7 Voltage-Gated Sodium Channel
  • Scn9a protein, rat
  • Sodium Channel Blockers
  • Sodium Channels